What's new in the diagnosis and management of painful bladder syndrome/interstitial cystitis?

Current Urology Reports

Volumn 9, Issue 5, 2008, Pages 349-357

  Seth, Abhishek ^b   Teichman, Joel M H ^a  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BCG VACCINE; BICARBONATE; BOTULINUM TOXIN A; CYCLOSPORIN A; HEPARIN; HYDROXYZINE; IMMUNOMODULATING AGENT; LIDOCAINE; MYCOPHENOLIC ACID; NARCOTIC AGENT; PENTOSAN POLYSULFATE; PLACEBO;

ALTERNATIVE MEDICINE; ANTICHOLINERGIC EFFECT; BLADDER DISTENSION; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CYSTOSCOPY; DIAGNOSTIC ACCURACY; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG WITHDRAWAL; FOOD PREFERENCE; HUMAN; INTERSTITIAL CYSTITIS; MICTURITION; MONOTHERAPY; NEUROMODULATION; PAINFUL BLADDER SYNDROME; PROSPECTIVE STUDY; REVIEW; SENSITIVITY AND SPECIFICITY; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; URINE RETENTION;

AMITRIPTYLINE; ANALGESICS, NON-NARCOTIC; CYSTITIS, INTERSTITIAL; CYSTOSCOPY; GLYCOPROTEINS; HUMANS; IMMUNOLOGIC FACTORS; MUCOPROTEINS; PENTOSAN SULFURIC POLYESTER; SENSITIVITY AND SPECIFICITY; UROLOGY;

EID: 51949116091     PISSN: 15272737     EISSN: 15346285     Source Type: Journal    
DOI: 10.1007/s11934-008-0061-9     Document Type: Review

References (88)

1. Pool TL, Rives HF: Interstitial cystitis: treatment with silver nitrate. J Urol 1944, 51:520-525.
2. Bojar S, Reich P: Psychosomatic aspects of urology. In Campell's Urology, edn 4. Edited by Harrison JH, Gittes RF, Perlmutter AD, et al. Philadelphia: Saunders; 1979:1906-1909.
3. Slobodov G, Feloney M, Gran C, et al.: Abnormal expression of molecular markers for bladder impermeability and differentiation in the urothelium of patients with interstitial cystitis. J Urol 2004, 171:1554-1558.
4. Parsons CL, Greenberger M, Gabal L, et al.: The role of urinary potassium in the pathogenesis and diagnosis of interstitial cystitis. J Urol 1998, 159:1862-1867.
5. Teichman JMH, Moldwin R: The role of the bladder surface in interstitial cystitis/painful bladder syndrome. Can J Urol 2007, 14:3599-3607.
6. Letourneau R, Sant GR, el-Mansoury M, et al.: Activation of bladder mast cells in interstitial cystitis. Int J Tissue React 1992, 14:307-312.
7. Tomaszewski JE, Landis JR, Russack V, et al.: Biopsy features are associated with primary symptoms in interstitial cystitis: results from the Interstitial Cystitis Database Study. Urology 2001, 57:67-81.
8. Hand JR: Interstitial cystitis: report of 223 cases (204 women and 19 men). J Urol 1949, 61:291-310.
9. Saban MR, Nguyen NB, Hammond TG, Sabar R: Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation. Am J Pathol 2002, 160:2095-2110.
10. Bjorling DE, Beckman M, Saban R: Neurogenic inflammation of the bladder. Adv Exp Med Biol 2003, 539:551-583.
11. Parsons CL, Stein P, Zupkas P, et al.: Defective Tamm-Horsfall protein in patients with interstitial cystitis. J Urol 2007, 178:2665-2670.
12. Peters KM, Kalinowski SE, Carrico DJ, et al.: Fact or fiction - is abuse prevalent in patients with interstitial cystitis? Results from a community survey and clinic population. J Urol 2007, 178:891-895.
13. Nazif O, Teichman JMH, Gebhart GF: Neural upregulation in interstitial cystitis. Urology 2007, 69:24-33.
14. Driscoll AM, Teichman JMH: How do interstitial cystitis patients present? J Urol 2001, 166:2118-2120.
15. Messing EM, Stamey TA: Interstitial cystitis: early diagnosis, pathology, and treatment. Urology 1978, 12:381-392.
16. Gillenwater JY, Wein AJ: Summary of the National Institute of Arthritis, Diabetes, Digestive, and Kidney Diseases Workshop on Interstitial Cystitis. J Urol 1988, 140:203-206.
17. Hanno PM, Landis JR, Matthews-Cook Y, et al.: The diagnosis of interstitial cystitis revisited: lessons learned from the National Institutes of Health Interstitial Cystitis Database study. J Urol 1999, 161:553-557.
18. Warren JW, Brown J, Tracy JK, et al.: Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology 2008, 71:444-448.
19. Mattox TF: Interstitial cystitis in adolescents and children: a review. J Pediatr Adolesc Gynecol. 2004, 17:7-11.
20. Payne CK, Terai A, Komatsu K: Research criteria versus clinical criteria for interstitial cystitis. Int J Urol 2003, 10:S7-S10.
21. Waxman JA, Sulak PJ, Kuehl TJ: Cystoscopic findings consistent with interstitial cystitis in normal women undergoing tubal ligation. J Urol 1998, 160:1663-1667.
22. Denson MA, Griebling TL, Cohen MB, et al.: Comparison of cystoscopic and histologic findings in patients with suspected interstitial cystitis. J Urol 2001, 164:1908-1911.
23. Erickson DR, Tomaszewski JE, Kunselman AR, et al.: Do the National Institute of Diabetes and Digestive and Kidney Diseases Cystoscopic criteria associate with other clinical and objective features of interstitial cystitis? J Urol 2005, 173:93-97.
24. Ottem DP, Teichman JMH: What is the value of cystoscopy with hydrodistension for interstitial cystitis? Urology 2005, 66:494-499.
25. Erickson DR, Tomaszewski JE, Kunselman AR, et al.: Urine markers do not predict bladder biopsy findings or presence of bladders ulcers in interstitial cystitis/painful bladder syndrome. J Urol 2008, 179:1850-1856.
26. Nickel JC: Interstitial cystitis: the paradigm shifts: international consultations on interstitial cystitis. Rev Urol 2004, 6:200-202.
27. Teichman JMH, Parsons CL: Contemporary clinical presentation of interstitial cystitis. Urology 2007, 69:41-47.
28. Ito T, Ueda T, Honma Y, Takei M: Recent trends in patient characteristics and therapeutic choices for interstitial cystitis: analysis of 282 Japanese patients. Int J Urol 2007, 14:1068-1070.
29. Parsons CL, Zupkas P, Parsons JK: Intravesical potassium sensitivity in patients with interstitial cystitis and urethral syndrome. Urology 2001, 57:428-433.
30. Minaglia S, Ozel B, Bizhang R, Mishell DR Jr: Increased prevalence of interstitial cystitis in women with detrusor overactivity refractory to anticholinergic therapy. Urology 2005, 66:702-706.
31. Evans RJ, Sant GR: Current diagnosis of interstitial cystitis: an evolving paradigm. Urology 2007, 69:64-72.
32. Berger RE, Miller JE, Rothman I, et al.: Bladder petechiae after cystoscopy and hydrodistension in men diagnosed with prostate pain. J Urol 1998, 159:83-85.
33. Parsons CL, Albo M: Intravesical potassium sensitivity in patients with prostatitis. J Urol 2002, 168:1054-1057.
34. Peters KM, Carrico DJ, Diokno AC: Characterization of a clinical cohort of 87 women with interstitial cystitis/painful bladder syndrome. Urology 2008, 71:634-640.
35. Diggs C, Meyer WA, Langenberg P, et al.: Assessing urgency in interstitial cystitis/painful bladder syndrome. Urology 2007, 69:210-214.
36. Greenberg P, Brown J, Yates T, et al.: Voiding urges perceived by patients with interstitial cystitis/painful bladder syndrome. Neurourol Urodyn 2008, 27:287-290.
37. Nickel JC, Teichman JMH, Gregoire M, et al.: Prevalence, diagnosis, characterization, and treatment of prostatitis, interstitial cystitis, and epididymitis in outpatient urological practice: the Canadian PIE study. Urology 2005, 66:935-940.
38. Parsons CL, Dell J, Stanford EJ, et al.: The prevalence of interstitial cystitis in gynecologic patients with pelvic pain, as detected by intravesical potassium sensitivity. Am J Obstet Gynecol 2002, 187:1395-1400.
39. Powell-Boone T, Ness TJ, Cannon R, et al.: Menstrual cycle affects bladder pain sensation in subjects with interstitial cystitis, J Urol 2005, 174:1832-1836.
40. Peters KM, Killinger KA, Carrico DJ, et al.: Sexual function and sexual distress in women with interstitial cystitis: a case-control study. Urology 2007, 70:543-547.
41. Zaslau S, Riggs D, Jackson B, Kandzari S: Update of the characterization of female sexual dysfunction in patients with interstitial cystitis 1000 respondents [abstract 301]. J Urol 2005, 173:83.
42. Ottem DP, Carr LK, Perks AE, et al.: Interstitial cystitis and female sexual dysfunction. Urology 2007, 69:608-610.
43. Duldulao KE, Diokno AC, Mitchell B: Value of urinary cytology in women presenting with urge incontinence and/ or irritative voiding symptoms. J Urol 1997, 157:113-136.
44. Tissot WD, Diokno AC, Peters KM: A referral center's experience with transitional cell carcinoma misdiagnosed as interstitial cystitis. J Urol 2004, 172:478-480.
45. Keay SK, Zhang CO, Shoenfelt J, et al.: Sensitivity and specificity of antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor as urine markers for interstitial cystitis. Urology 2001, 57:9-14.
46. Zhang CO, Li ZL, Shoenfelt JL, et al.: Comparison of APF activity and epithelial growth factor levels in urine from Chinese, African-American, and white American patients with interstitial cystitis. Urology 2003, 61:897-901.
47. Chai TC, Zhong C, Warren JW, Keay S: Percutaneous sacral third nerve root neurostimulation improves symptoms and normalizes urinary HB-EGF levels and antiproliferative activity in patients with interstitial cystitis. Urology 2000, 55:643-646.
48. Erickson DR, Kunselman AR, Bentley CM, et al.: Changes in urine markers and symptoms after bladder distention for interstitial cystitis. J Urol 2007, 177:556-560.
49. Keay S, Zhang CO, Chai T, et al.: Antiproliferative factor, heparin-binding epidermal growth factor-like growth factor, and epidermal growth factor in men with interstitial cystitis versus chronic pelvic pain syndrome. Urology 2004, 63:22-26.
50. Bates JM, Raffi HM, Prasadan K, et al.: Tamm-Horsfall protein knockout mice are more prone to urinary tract infection: rapid communication. Kidney Int 2004, 65:791-797.
51. Akiyama A, Stein PC, Houshiar A, Parsons CL: Urothelial cytoprotective activity of Tamm-Horsfall protein isolated from the urine of healthy subjects and patients with interstitial cystitis. Int J Urol 2000, 7:176-183.
52. Parsons CL, Rajasekaran M, Arsanjani AH, et al.: Role of sialic acid in urinary cytoprotective activity of Tamm-Horsfall protein. Urology 2007, 69:577-581.
53. Daha LK, Riedl CR, Hohlburgger G, et al.: Comparative assessment of maximal bladder capacity, 0.9% NaCl versus 0.2 M Kcl, for the diagnosis of interstitial cystitis: a prospective controlled study. J Urol 2003, 170:807-809.
54. Philip J, Willnott S, Owen D, et al.: A double-blind, randomized controlled trial of cystometry using saline versus 0.3 M potassium chloride infusion in women with overactive bladder syndrome. Neurourol Urodyn 2007, 26:110-114.
55. Teichman JMH, Nielson-Omeis BJ, Mclver BD: Modified urodynamics for interstitial cystitis. Tech Urol 1997, 3:65-68.
56. Shorter B, Lesser M, Moldwin RM, Kushner L: Effect of comestibles on symptoms of interstitial cystitis. J Urol 2007, 178:145-152.
57. Bologna RA, Gomelsky A, Lukban JC, et al.: The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology 2001, 57:119-120.
58. Lutgendorf SK, Latini JM, Rothrock NE, et al.: Autonomic response to stress in interstitial cystitis. J Urol 2004, 172:227-231.
59. Spanos C, Pang X, Ligris K, et al.: Stress-induced bladder mast cell activation: implications for interstitial cystitis. J Urol 1997, 157:669-672.
60. Ripoll E, Mahowald D: Hatha Yoga therapy management of urologic disorders. World J Urol 2002, 20:306-309.
61. Webster DC, Brennan T: Use and effectiveness of psychological self-care strategies for interstitial cystitis. Health Care Women Int 1995, 16:463-475.
62. Whitmore KE: Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol 2002, 4:S28-S35.
63. Geirsson G, Wang YH, Lindstrom S, Fall M: Traditional acupuncture and electrical stimulation of the posterior tibial nerve. A trial in chronic interstitial cystitis. Scand J Urol Nephrol 1993, 27:67-70.
64. O'Reilly BA, Dwyer PL, Hawthorne G, et al.: Transdermal posterior tibial nerve laser therapy is not effective in women with interstitial cystitis. J Urol 2004, 172:1880-1883.
65. Parsons CL, Benson G, Childs SJ, et al.: A quantitatively controlled method to study prospectively interstitial cystitis and demonstrate the efficacy of pentosan polysulate. J Urol 1993, 150:845-848.
66. Sant GR, Propert KJ, Hanno PM, et al.: A pilot clinical trial of oral pentosan polysulfate and oral hydroxyzine in patients with interstitial cystitis. J Urol 2003, 170:810-815.
67. Nickel JC, Barkin J, Forrest J, et al.: Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis. Urol 2005, 65:654-658.
68. Davis EL, El Khoudary SR, Talbott EO, et al.: Safety and efficacy of the use of intravesical and oral pentosan polysulfate sodium for interstitial cystitis: a randomized double-blind clinical trial. J Urol 2008, 179:177-185.
69. Van Ophoven A, Pokupic S, Heinecke H, Hertle L: A prospective, randomized, placebo controlled, double-blind study of amitriptyline for the treatment of interstitial cystitis. J Urol 2004, 172:533-536.
70. Van Ophoven A, Hertle L: The dual serotonin and noradrenaline reuptake inhibitor duloxetine for the treatment of interstitial cystitis: results of an observational study. J Urol 2007, 177:552-555.
71. Sairanen J, Tammela TL, Leppilahti M, et al.: Cyclosporine A and pentosan polysulfate sodium for the treatment of interstitial cystitis: a randomized comparative study. J Urol 2005, 174:2235-2238.
72. Sairanen J, Forsell T, Ruutu M: Long-term outcome of patients with interstitial cystitis treated with low dose cyclosporine A. J Urol 2004, 171:2138-2141.
73. ClinicalTrials.gov. A randomized multicenter double-blind CT to evaluate the efficacy and safety of mycophenolate mofetil. Available at http://clinicaltrials.gov/ct2/show/NCT00451867?term= mycophenolate+and+interstitial+cystitis&rank=1. Accessed June 2008.
74. Zabihi N, Mourtzinos A, Maher MG, et al.: Short-term results of bilateral S2-S4 sacral neuromodulation for the treatment of refractory interstitial cystitis, painful bladder syndrome, and chronic pelvic pain. Int J Urogynecol J Pelvic Floor Dysfunct 2008, 19:553-557.
75. Peters KM, Konstandt D: Sacral neuromodulation decreases narcotic requirements in refractory interstitial cystitis. BJU Int 2004, 93:777-779.
76. Comiter CV: Sacral neuromodulation for the symptomatic treatment of refractory interstitial cystitis: a prospective study. J Urol 2003, 169:1369-1373.
77. Aboseif S, Tamaddon K, Chalfin S, et al.: Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology 2002, 60:52-56.
78. Maxwell KM, Clemens JQ, Mazzenga L, Kielb SJ: Reprogramming requirements after sacral nerve stimulator implantation: correlation with preoperative indication. J Urol 2008, 179:549-551.
79. Burks FN, Diokno AC, Lajiness MJ, et al.: Sacral neuromodulation reprogramming: is it an office burden? Int Urogynecol J Pelvic Floor Dysfunct 2008 (in press).
80. Moldwin RM, Evans RJ, Stanford EJ, Rosenberg MT: Rational approaches to the treatment of patients with interstitial cystitis. Urology 2007, 69:73-81.
81. Peters K, Diokno A, Steinert B, et al.: The efficacy of intravesical Tice strain bacillus Calmette-Guerin in the treatment of interstitial cystitis: a double-blind, prospective, placebo controlled trial. J Urol 1997, 157:2090-2094.
82. Mayer R, Propert KJ, Peters KM, et al.: A randomized controlled trial of intravesical bacillus Calmette-Guerin for treatment refractory interstitial cystitis. J Urol 2005, 173:1186-1191.
83. Propert KJ, Mayer R, Nickel JC, et al.: Followup of patients with interstitial cystitis responsive to treatment with intravesical bacillus Calmette-Guerin or placebo. J Urol 2008, 179:552-555.
84. Propert KJ, Mayer R, Nickel JC, et al.: Did patients with interstitial cystitis who failed to respond to initial treatment with bacillus Calmette-Guerin or placebo in a randomized clinical trial benefit from a second course of open label bacillus Calmette-Guerin? J Urol 2007, 178:886-870.
85. Henry R, Patterson L, Avery N, et al.: Absorption of alkalinized intravesical lidocaine in normal and inflamed bladders: a simple method for improving bladder anesthesia. J Urol 2001, 165:1900-1903.
86. Parsons CL: Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis. Urology 2005, 65:45-48.
87. Welk BK, Teichman JMH: Dyspareunia response in patients with interstitial cystitis treated with intravesical lidocaine, bicarbonate, and heparin. Urology 2008, 71:67-70.
88. Giannantoni A, Porena M, Costantini E, et al.: Botulinum A toxin intravesical injection in patients with painful bladder syndrome: 1-year followup. J Urol 2008, 179:1031-1034.